^
    CANCER:

    Thymus Cancer

    Contact us to learn more about our Premium Content:
    News alerts, weekly reports and conference planners
    Related cancers:
    No biomarker
    Thymic Carcinoma
    lenvatinib
    Sensitive
    :
    A1
    No biomarker
    Thymic Carcinoma
    GEM-CAP
    Sensitive
    :
    A2
    No biomarker
    Thymic Carcinoma
    LV5FU2
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    GEM-CAP
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    LV5FU2
    Sensitive
    :
    A2
    No biomarker
    Thymic Carcinoma
    CaT
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    CaT
    Sensitive
    :
    A2
    KIT mutation
    Thymic Carcinoma
    sunitinib
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    VIP
    Sensitive
    :
    A2
    No biomarker
    Thymic Carcinoma
    VIP
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    CAP
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    etoposide IV
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    ifosfamide
    Sensitive
    :
    A2
    No biomarker
    Thymic Carcinoma
    EP
    Sensitive
    :
    A2
    No biomarker
    Thymic Carcinoma
    ADOC
    Sensitive
    :
    A2
    No biomarker
    Thymic Carcinoma
    CAP + prednisone
    Sensitive
    :
    A2
    No biomarker
    Thymic Carcinoma
    CAP
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    CAP + prednisone
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    ADOC
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    EP
    Sensitive
    :
    A2
    No biomarker
    Thymic Carcinoma
    carboplatin
    Sensitive
    :
    A2
    No biomarker
    Thymic Carcinoma
    paclitaxel
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    carboplatin
    Sensitive
    :
    A2
    No biomarker
    Thymoma
    pembrolizumab
    Resistant
    :
    A2
    No biomarker
    Thymic Carcinoma
    ifosfamide
    Sensitive
    :
    A2
    No biomarker
    Thymic Carcinoma
    etoposide oral
    Sensitive
    :
    A2
    No biomarker
    Thymic Carcinoma
    pembrolizumab
    Sensitive
    :
    A2
    No biomarker
    Thymic Carcinoma
    gemcitabine
    Sensitive
    :
    A2
    No biomarker
    Thymic Carcinoma
    prednisone + octreotide
    Sensitive
    :
    A2
    No biomarker
    Thymic Carcinoma
    octreotide
    Sensitive
    :
    A2
    No biomarker
    Thymic Carcinoma
    everolimus
    Sensitive
    :
    A2
    No biomarker
    Thymic Carcinoma
    pemetrexed
    Sensitive
    :
    A2